Risk Factors for New Zealand Sea Lion (Phocarctos hookeri) Pup Mortality: Ivermectin Improves Survival for Conservation Management


World Heritage Site: New Zealand Sub-Antarctic Islands

Publication Year: 2021

Publication Type: Article

Publication Identifier: WHEDA973EDBA3

Summary

Ivermectin treatment significantly reduces pup mortality in endangered New Zealand sea lions (Phocarctos hookeri) at Enderby Island, offering a potential conservation strategy. The study found that ivermectin-treated pups had 57% lower mortality rates compared to controls, particularly due to hypervirulent Klebsiella pneumoniae septicaemia—a leading cause of neonatal deaths since an epizootic in 2001–02. Researchers conducted case-control and cohort studies alongside a treatment trial over two field seasons (2016–2018), analyzing risk factors including bacterial carriage, body condition index, and hookworm presence. While the mechanism by which ivermectin prevents septicaemia remains unclear, preemptive anthelmintic treatment may limit systemic bacterial spread. This intervention could benefit larger colonies if applied broadly, though further research is needed to optimize its use for population-scale conservation.

Citation

Michael, S. A., Hayman, D. T. S., Gray, R., & Roe, W. D. (2021). Risk Factors for New Zealand Sea Lion (Phocarctos hookeri) Pup Mortality: Ivermectin Improves Survival for Conservation Management. Frontiers in Marine Science, 8. https://doi.org/10.3389/fmars.2021.680678

You are here:
World Heritage Explorer > World Heritage Research > Publications > Risk Factors for New Zealand Sea Lion (Phocarctos hookeri) Pup Mortality: Ivermectin Improves Survival for Conservation Management

This website includes data sources licensed under CC BY-SA 4.0. Additional original content by World Heritage Explorer, also licensed under CC BY-SA 4.0. WHE is not affiliated with UNESCO or the World Heritage Committee. Legal Notice. Privacy Policy.

Open Data for an Open World